Related Experiment Video
Updated: Nov 28, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.7K
Overcoming Immune Evasion in Melanoma
Kevinn Eddy1,2, Suzie Chen1,2,3,4
1Graduate Program in Cellular and Molecular Pharmacology, School of Graduate Studies Rutgers University, Piscataway, NJ 08854, USA.
International Journal of Molecular Sciences
|December 1, 2020
Summary
Early detection of melanoma is key for curability. Advanced melanoma treatment focuses on molecular mechanisms and immune evasion strategies, utilizing targeted therapies and immunotherapies for improved patient outcomes.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Melanoma is an aggressive skin cancer originating from melanocytes.
- Early-stage melanoma is curable, but metastatic melanoma has a poor prognosis (25% five-year survival).
- Advances in understanding melanoma etiology have led to targeted therapies and immunotherapies for advanced stages.
Purpose of the Study:
- To review molecular mechanisms of melanoma development and progression.
- To focus on melanoma's immune evasion strategies.
- To discuss immunotherapeutic agents and adoptive T-cell therapy for advanced melanoma.
Main Methods:
- Literature review of molecular mechanisms in melanoma.
- Analysis of immune evasion strategies employed by melanoma cells.
- Discussion of therapeutic agents including vemurafenib, ipilimumab, nivolumab, pembrolizumab, atezolizumab, and T-VEC.
Main Results:
- Melanoma progression involves complex molecular pathways.
- Tumor cells employ sophisticated immune evasion tactics.
- Several immunotherapies show promise in treating advanced melanoma.
Conclusions:
- Understanding melanoma's molecular drivers and immune evasion is crucial.
- Identifying biomarkers for treatment response is critical.
- Improved strategies are needed to enhance clinical outcomes for melanoma patients.
Related Concept Videos
01:27Tumor Immunotherapy
899
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
899
01:30Cancer Vaccines
677
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
677
02:53Adaptive Mechanisms in Cancer Cells
6.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.3K
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
01:25Immune Surveillance by NK Cells and Phagocytes
7.3K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.3K